Fecal carriage of extended-spectrum β-lactamase- and AmpC- producing escherichia coli among healthcare workers

Journal of Infection in Developing Countries

Volumn 9, Issue 3, 2015, Pages 304-308

  Bassyouni, Rasha H ^a   Gaber, Sylvana Nady ^a   Wegdan, Ahmed Ashraf ^a  

^a FAYOUM UNIVERSITY   (Egypt)

Author keywords

AmpC; E. coli; ESBL; HCWs

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; BETA LACTAMASE AMPC; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; ANTIINFECTIVE AGENT; BACTERIAL DNA; BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; DISK DIFFUSION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FECES ANALYSIS; FECES MICROFLORA; GENETIC SCREENING; HEALTH CARE PERSONNEL; HUMAN; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; PHENOTYPE; DRUG EFFECTS; ENZYMOLOGY; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; GENETICS; HETEROZYGOTE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; POLYMERASE CHAIN REACTION; PREVALENCE; SECRETION (PROCESS);

ESCHERICHIA COLI;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARRIER STATE; DNA, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FECES; HEALTH PERSONNEL; HUMANS; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; PREVALENCE;

EID: 84924873867     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.5633     Document Type: Article

References (24)

1. Yano H, Uemura M, Endo S, Kanamori H, Inomata S, Kakuta R, Ichimura S, Ogawa M, Shimojima M, Ishibashi N, Aoyagi T, Hatta M, Yamada M, Tokuda K, Kunishima H, Kitagawa M, Hirakata Y, Kaku M (2013) Molecular characteristics of extended-spectrum β-lactamases in clinical isolates from E. coli at a Japanese Tertiary Hospital. PLoS One 8:.
2. Valverde A, Coque T, Sánchez-Moreno M, Rollán A, Baquero F, Cantón R (2004) Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during non outbreak situations in Spain. J Clin. Microbiol 42: 4769-4775.
3. Machado E, Coque T, Cantón R, Sousa JC, Peixe L (2013) Commensal Enterobacteriaceae as reservoirs of ESBL, integrons, and sul genes in Portugal. Front Microbiol 4: 1-7. doi: 10.3389/fmicb.2013.00080.
4. Lonchel C, Meex C, Gangoué-Piéboji J, Boreux R, Assoumou MO, Melin P, De Mol P (2012) Proportion of Extendedspectrum ß-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon. BMC Infect Dis 12: 1-7.
5. Ko Y, Moon H, Hur M, Park CM, Cho SE, Yun YM (2013) Fecal carriage of Extended-spectrum β-lactamase-producing Enterobacteriaceae in Korean community and hospital settings. Infection 41: 9-13.
6. Adler A, Baraniak A, Izdebski R, Fiett J, Salvia A, Samso JV, Lawrence C, Solomon J, Paul M, Lerman Y, Schwartzberg Y, Mordechai E, Rossini A, Fierro J, Lammens C, Malhotra-Kumar S, Goossens H, Hryniewicz W, Brun-Buisson C, Gniadkowski M, Carmeli Y; MOSAR team (2014) A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centers. Clin Microbiol Infect 20: 516-523.
7. Yilmaz N, Agus N, Bozcal E, Oner O, Uzel A (2013) Detection of plasmid-mediated AmpC β-lactamase in E. coli and K.pneumoniae. Indian J Med Microbiol 31: 53-59.
8. Ewing WH (1986) The Genus Escherichia. In Edwards and Ewing, editors. Edwards and Ewing’s Identification of Enterobacteriaceae, 4th ed. New York: Elsevier Science Publishing Co. 93-122.
9. Hussain M, Hasan F, Shah A, Hameed A, Jung M, Rayamajhi N, Cha SB, Yoo HS (2011) Prevalence of class A and AmpC β-lactamases in clinical E. coli isolates from Pakistan institute of medical science, Islamabad, Pakistan. Jpn J Infect Dis 64: 249-252.
10. Laghawe A, Jaitly N, Thombare V (2012) The simultaneous detection of the ESBL and the AmpC β-lactamases in gram negative bacilli. J Clin Diagn Res 6: 660-663.
11. Clinical and Laboratory Standards Institute (CLSI) (2012) Performance standards for Antimicrobial Susceptibility Testing. 22 Informational Supplement ed. CLSI document M100-S22. Wayne, PA.
12. Tan TY, Ng LS, He J, Koh TH, Hsu LY (2009) Evaluation of screening methods to detect plasmid-mediated AmpC in E. coli, K. pneumoniae, and P. mirabilis. Antimicrob Agents Chemother 53: 146-149.
13. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G (2010) Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65: 490-495.
14. Pérez-Pérez F, Hanson N (2002) Detection of plasmid-mediated AmpC β-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40: 2153-2162.
15. Kader A, Kamath K (2009) Faecal carriage of ESBLproducing bacteria in the community. East Mediterr Health J 15: 1365-1370.
16. Ben Sallem R, Ben Slama K, Estepa V, Jouini A, Gharsa H, Klibi N, Sáenz Y, Ruiz-Larrea F, Boudabous A, Torres C (2012) Prevalence and characterisation of ESBL-producing E. coli isolates in healthy volunteers in Tunisia. Eur J Clin. Microbio Infect Dis 31: 1511-1516.
17. Archibald L, Phillips L, Monnet D, Johnson JK, Harris AD, Furuno JP, Thom KA, Snyder GM, Day HR, Perencevich EN (2010) Frequent multidrug-resistant Acinetobacter baumannii contamination of gloves, gowns, and hands of healthcare workers. Infect Control Hosp Epidemiol 31: 716-721.
18. Naseer U, Haldorsen B, Simonsen G, Sundsfjord A (2010) Sporadic occurrence of CMY-2-producing multidrugresistant E. coli of ST-complexes 38 and 448, and ST131 in Norway. Clin Microbiol Infect 16: 171-178.
19. Li Y, Li Q, Du Y, Jiang X, Tang J, Wang J, Li G, Jiang Y (2008) Prevalence of plasmid-mediated AmpC β-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC β-lactamase resistance in China. J Clin Microbiol 46: 1317-1321.
20. Husickova V, Cekanova L, Chroma M, Htoutou-Sedlakova M, Hricova K, Kolar M (2012) Carriage of ESBL- and AmpC-positive Enterobacteriaceae in the GIT of community subjects and hospitalized patients in the Czech Republic. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 156: 348-353.
21. Hammerum A, Lester C, Jakobsen L, Porsbo LJ (2011) Faecal carriage of ESBL-producing and AmpC β-lactamase-producing bacteria among Danish army recruits. Clin Microbial Infect 17: 566-568.
22. Ahmed S, Daef E, Badary M, Mahmoud MA, Abd-Elsayed AA (2009) Nosocomial blood stream infection in ICUs at Assiut University Hospitals (Upper Egypt) with special reference to ESBL producing organisms. BMC Res Notes 6: 76.
23. Nicolas-Chanoine M, Gruson C, Bialek-Davenet S, Bertrand X, Thomas-Jean F, Bert F, Moyat M, Meiller E, Marcon E, Danchin N, Noussair L, Moreau R, Leflon-Guibout V (2013) 10-Fold increase (2006-11) in the rate of healthy subjects with ESBL –producing E. coli faecal carriage in a Parisian checkup centre. J Antimicrob Chemother 68: 562-568.
24. Isendahl J, Turlej-Rogacka A, Manjuba C, Rodrigues A, Giske CG, Nauclér P (2012) Fecal carriage of ESBLproducing E. coli and K. pneumoniae in children in GuineaBissau: a hospital-based cross-sectional study. PLoS One 7: 51981.